Sarepta Therapeutics, Inc. (SRPT)
Data as of , from SEC Form 4 filings.
See up to 3 months of SRPT. The 7-day demo opens the 1M and 3M ranges and puts SRPT on your watchlist.
Start 7-day demoLatest SRPT insider trades
About Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. is an SEC registrant, filing under CIK 0000873303, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
SRPT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 2,980,446 | |
| Tax withholding / forfeiture | 4 | 81,519 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SRPT insider transactions (Form 4)
3550 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| M. Kathleen Behrens | Option exercise | Common Stock | 10,500 | $13.71 | $144K | |
| M. Kathleen Behrens | Option exercise | Stock Option (right to buy) | 10,500 | $0.00 | - | |
| M. Kathleen Behrens | Tax withholding / forfeiture | Common Stock | 6,494 | $22.17 | $144K | |
| Michael Andrew Chambers | Derivative | Convertible Senior Notes | 0 | - footnote F1 | - | |
| Michael Andrew Chambers | Grant or award | Convertible Senior Notes | 0 | - footnote F1 | - | |
| ||||||
| Ian Michael Estepan - Officer | Open-market sale | Common Stock | 13,187 footnote F1 | $22.31 footnote F2 | $294K | |
| ||||||
| Ryan Ho-Yan Wong - Officer | Tax withholding / forfeiture | Common Stock | 80 | $20.96 | $2K | |
| Ryan Ho-Yan Wong - Officer | Tax withholding / forfeiture | Common Stock | 78 | $20.96 | $2K | |
| Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | ||
| Grant or award | Common Stock | 50,000 footnote F2 | $0.00 | - | ||
| Grant or award | Common Stock | 73,001 footnote F3 | $0.00 | - | ||
| Grant or award | Common Stock | 96,541 footnote F4 | $0.00 | - | ||
| Grant or award | Common Stock | 269,542 footnote F5 | $0.00 | - | ||
| ||||||
| Cristin Rothfuss - Officer | Tax withholding / forfeiture | Common Stock | 229 footnote F1 | $21.12 | $5K | |
| ||||||
| Louise Rodino-Klapac - Officer | Tax withholding / forfeiture | Common Stock | 4,582 footnote F1 | $18.42 | $84K | |
| ||||||
| Ryan Ho-Yan Wong - Officer | Grant or award | Common Stock | 93,875 | $0.00 | - | |
| Ryan Ho-Yan Wong - Officer | Grant or award | Common Stock | 25,000 | $0.00 | - | |
| Cristin Rothfuss - Officer | Grant or award | Common Stock | 93,875 | $0.00 | - | |
| Cristin Rothfuss - Officer | Grant or award | Common Stock | 25,000 | $0.00 | - | |
| Ian Michael Estepan - Officer | Grant or award | Common Stock | 93,875 | $0.00 | - | |
| Ian Michael Estepan - Officer | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Louise Rodino-Klapac - Officer | Grant or award | Common Stock | 93,875 | $0.00 | - | |
| Louise Rodino-Klapac - Officer | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Bilal Arif - Officer | Grant or award | Performance Stock Units | 6,250 | $0.00 | - | |
| Ian Michael Estepan - Officer | Grant or award | Performance Stock Units | 6,250 | $0.00 | - | |
| Louise Rodino-Klapac - Officer | Grant or award | Performance Stock Units | 6,250 | $0.00 | - | |
| Ryan Ho-Yan Wong - Officer | Tax withholding / forfeiture | Common Stock | 327 | $16.42 | $5K | |
| Ian Michael Estepan - Officer | Gift | Common Stock | 250 | $0.00 | - | |
| Hans Lennart Rudolf Wigzell | Option exercise | Common Stock | 10,500 | $13.71 | $144K | |
| Hans Lennart Rudolf Wigzell | Open-market sale | Common Stock | 10,500 | $124.84 | $1.31M | |
| Hans Lennart Rudolf Wigzell | Option exercise | Stock Options (right to buy) | 10,500 | $0.00 | - | |
| Kathryn Jean Boor | Open-market sale | Common Stock | 1,636 | $125.55 | $205K | |
| Cristin Rothfuss - Officer | Grant or award | Common Stock | 2,000 | $0.00 | - | |
| Cristin Rothfuss - Officer | Grant or award | Stock Option (right to buy) | 4,000 | $0.00 | - | |
| Louise Rodino-Klapac - Officer | Tax withholding / forfeiture | Common Stock | 4,558 | $102.89 | $469K | |
SRPT insider trading FAQ
What is the latest insider trade for SRPT?
Sarepta Therapeutics, Inc. (SRPT) had 5 insider filings in the last 90 days, with the most recent on 2026-09-09. The full record for SRPT runs to 50 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SRPT stock?
No insider purchases of SRPT were filed in the last 90 days.
How many insiders are selling SRPT stock?
No insider sales of SRPT were filed in the last 90 days. 4 sales are on record for this company.
Where can I see SRPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SRPT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ryan Ho-Yan Wong view on EDGAR
- - Ian Michael Estepan view on EDGAR
- - Cristin Rothfuss view on EDGAR
- - Louise Rodino-Klapac view on EDGAR
- - Michael Severino view on EDGAR
- - Kathryn Jean Boor view on EDGAR
- - Stephen Mayo view on EDGAR
- - Hans Lennart Rudolf Wigzell view on EDGAR
- - M. Kathleen Behrens view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SRPT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SRPT with a 7-day demo
- SRPT on your watchlist
- Every SRPT Form 4 filing on record
- Up to 3 months of SRPT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive